Dr Akhil Santhosh MD DM MRCP(UK) (@tuttsakhil) / X

Dr Akhil Santhosh MD DM MRCP(UK)

4,563 posts

Dr Akhil Santhosh MD DM MRCP(UK)

@tuttsakhil

Consultant Med Onc (MVRCCRI) DM Med onc, AIIMS Delhi(Gold Medal) MD Medicine PGIMER MBBS JIPMER MRCP UK SCE onco ECMO ASCO IDEA Winner 2025 CAS in GI onc ESO

Calicut, Kerala.

Joined December 2023

Pinned
Dr Akhil Santhosh MD DM MRCP(UK)
@tuttsakhil
May 30, 2025
Honoured and privileged to receive the ASCO 2025 International Development Education Award (IDEA).. Grateful to all my teachers and mentors who made this happen. @MVRCancerCentre @aiims_newdelhi @oncologistindia @stolaney1 @ConquerCancerFd @ASCO
9.6K
Dr Akhil Santhosh MD DM MRCP(UK)
@tuttsakhil
Nov 30, 2024
Mechanism of resistance to 3rd generation EGFR TKis and subsequent options available @NatRevClinOncol
16K
Dr Akhil Santhosh MD DM MRCP(UK)
@tuttsakhil
Jan 25, 2025
Very simple algorithm for treatment planning in rectal cancer with the help of a dedicated rectal MRI
14K
Dr Akhil Santhosh MD DM MRCP(UK)
@tuttsakhil
Jan 29, 2025
Quick revision: Comparison between Monarch E and NATALEE
17K
Dr Akhil Santhosh MD DM MRCP(UK)
@tuttsakhil
Jan 20, 2025
Money slide💰: Snapshot of survival data for all 1st line CDK4i trials in advanced breast cancer
11K
Dr Akhil Santhosh MD DM MRCP(UK)
@tuttsakhil
Jan 11, 2025
Happy to share that I am among the recipients of the ASCO IDEA award 2025. Thanks to all my teachers and mentors in @aiims_newdelhi @OfficialJipmer and PGIMER @batraatulmd @DrGPrakash @oncologistindia @MVRCancerCentre @DrJasminPorwall @aparna96 @Amolpatel_dr @samdoc_mamc @ASCO
8.4K
Dr Akhil Santhosh MD DM MRCP(UK)
@tuttsakhil
Jun 29, 2025
Latest PFS and OS update from SOLO1 and PAOLA1 trials @myESMO
8K
Dr Akhil Santhosh MD DM MRCP(UK)
@tuttsakhil
Dec 11, 2024
Use of oncotype dx and clinical risk to predict benefit of chemo 👉for < 50 yr old node neg: RS score 16-20, benefit of chemo 1.5%, for 20-25, benefit is 6.5% @myESMO
5.7K
Dr Akhil Santhosh MD DM MRCP(UK)
@tuttsakhil
Jan 18, 2025
The SPARTAN, PROSPER and ARAMIS trials improve OS with apalutamide, enzalutamide and darolutamide respectively in non metastatic CRPC
5.9K
Dr Akhil Santhosh MD DM MRCP(UK)
@tuttsakhil
Dec 31, 2024
Snapshot of all adjuvant/periop IO based therapies in nsclc
11K
Dr Akhil Santhosh MD DM MRCP(UK)
@tuttsakhil
Jun 30, 2025
List of adjuvant imatinib trials in resected GIST @ASCO @samdoc_mamc
8K
Dr Akhil Santhosh MD DM MRCP(UK)
@tuttsakhil
Jan 17, 2025
Summary slide of all first line ADT+ARPI combinations in MCSPC
7.1K
Dr Akhil Santhosh MD DM MRCP(UK)
@tuttsakhil
Feb 3, 2025
Summary slide: phase 3 trials of PARPi with ARSI in mCRPC. Small addition- Talapro 2 recently met the OS end point for all comers irrespective of HRR.
9.2K
Dr Akhil Santhosh MD DM MRCP(UK)
@tuttsakhil
Dec 24, 2024
The GO 2 trial showed that 60-80% of cape0x dosing in Elderly and frail for advanced gastric cancer doesn't compromise survival outcomes, with improved QOL
5.4K